A retrospective study led by University of Cincinnati Cancer Center researchers showed that a device that acts as a GPS for surgeons to locate and remove breast and lymph node tumors was safe and effective.
Women who are 65 years old or older with high-risk breast cancer and are treated with chemotherapy are more likely to develop a substantial decline in physical function, a UCLA-led study suggests.
